Drug Profile
Research programme: HIV vaccine - Etubics Corporation
Alternative Names: Preventative HIV-1 vaccine - EtubicsLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Etubics Corporation
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in HIV-1-infections(Prevention) in USA (Parenteral, Injection)
- 29 Jul 2010 Preclinical development is ongoing in USA (Parenteral)
- 27 Aug 2007 Preclinical trials in HIV-1 infections in USA (unspecified route)